Hennion & Walsh Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.01M | Sell |
6,756
-39
| -0.6% | -$17.4K | 0.12% | 221 |
|
|
2025
Q1 | $3.29M | Sell |
6,795
-1,331
| -16% | -$645K | 0.15% | 178 |
|
|
2024
Q4 | $3.27M | Buy |
8,126
+554
| +7% | +$223K | 0.15% | 177 |
|
|
2024
Q3 | $3.52M | Sell |
7,572
-17
| -0.2% | -$7.91K | 0.16% | 157 |
|
|
2024
Q2 | $3.56M | Buy |
7,589
+583
| +8% | +$273K | 0.18% | 135 |
|
|
2024
Q1 | $2.93M | Buy |
7,006
+515
| +8% | +$215K | 0.16% | 175 |
|
|
2023
Q4 | $2.64M | Buy |
6,491
+955
| +17% | +$389K | 0.15% | 196 |
|
|
2023
Q3 | $1.93M | Buy |
5,536
+1,412
| +34% | +$491K | 0.12% | 223 |
|
|
2023
Q2 | $1.45M | Buy |
4,124
+827
| +25% | +$291K | 0.09% | 287 |
|
|
2023
Q1 | $1.04M | Buy |
3,297
+1,472
| +81% | +$464K | 0.06% | 348 |
|
|
2022
Q4 | $527K | Buy |
1,825
+262
| +17% | +$75.7K | 0.03% | 488 |
|
|
2022
Q3 | $453K | Buy |
+1,563
| New | +$453K | 0.03% | 500 |
|